Trolamine

Trolamine

SCHEMBL5032871

CCN(CC)CC.OCCN(CCO)CCO.[Cl-].[Cl-].[Ni+2]

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Trolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.48
CYP2C9 P11712 1/20 0.48
HPGD P15428 1/20 0.48
MAPK1 P28482 1/20 0.48
HIF1A Q16665 1/20 0.48
HSD17B10 Q99714 1/20 0.48
MAPT P10636 2/20 0.38
CYP2D6 P10635 2/20 0.36
ALDH1A1 P00352 3/20 0.36
ALDH2 P05091 1/20 0.36
ARG1 P05089 1/20 0.32
ARG2 P78540 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALOX15 P16050 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
LMNA P02545 1/20 0.31
SLC29A1 Q99808 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trolamine SCHEMBL5034081 0.94 CYP1A2 (0.48) CYP1A2CYP2C9HPGDMAPK1HIF1A
Trolamine SCHEMBL220505 0.94 CYP1A2 (0.52) CYP1A2CYP2C9HPGDMAPK1HIF1A
Trolamine SCHEMBL2160601 0.88 CYP1A2 (0.48) CYP1A2CYP2C9HPGDMAPK1HIF1A
Trolamine SCHEMBL11520004 0.88 CYP1A2 (0.58) CYP1A2CYP2C9HPGDMAPK1HIF1A
Trolamine SCHEMBL22749413 0.88 CYP1A2 (0.52) CYP1A2CYP2C9HPGDMAPK1HIF1A
SCHEMBL21531945 0.85 CYP1A2 (0.56) CYP1A2CYP2C9HPGDMAPK1HIF1A
SCHEMBL2845423 0.85 CYP1A2 (0.50) CYP1A2CYP2C9HPGDMAPK1HIF1A
Diethylaminoethanol SCHEMBL3114 0.84
Diethylaminoethanol SCHEMBL10699915 0.84
SCHEMBL35602 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120309952-A1 SMALL RNA PURIFICATION PROMEGA CORPORATION (US) 2012-12-06 US disclosed
EP-1996730-A2 SMALL RNA PURIFICATION PROMEGA CORPORATION (US) 2008-12-03 EP disclosed
US-20070249821-A1 Small RNA purification PROMEGA CORPORATION (US) 2007-10-25 US disclosed
WO-2007103485-A2 SMALL RNA PURIFICATION PROMEGA CORPORATION (US) 2007-09-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249821-A1 Small RNA purification ZFR, EMG1, SNRPA1 CYP1A2 4840/4885CYP2C9 4879/4885HPGD 4850/4885
US-20120309952-A1 SMALL RNA PURIFICATION ZFR, EMG1, SNRPA1 CYP1A2 4840/4885CYP2C9 4879/4885HPGD 4850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.